Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients

Abstract Classification of patients with rheumatoid arthritis (RA) as quickly as possible improves their prognosis. This reason motivates specially dedicated early arthritis (EA) clinics. Here, we have used 1062 EA patients with two years of follow-up to explore the value of anti-carbamylated protei...

Full description

Bibliographic Details
Main Authors: Cristina Regueiro, Laura Nuño, Ana M. Ortiz, Diana Peiteado, Alejandro Villalba, Dora Pascual-Salcedo, Ana Martínez-Feito, Isidoro González-Alvaro, Alejandro Balsa, Antonio González
Format: Article
Language:English
Published: Nature Publishing Group 2017-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-09657-5

Internet

https://doi.org/10.1038/s41598-017-09657-5

Similar Items